1. Opposing therapeutic efficacy of BET inhibitors is determined by cancer type-specific SPOP mutants. (December 2016) Authors: Janouskova, H.; El Tekle, G.; Udeshi, N.; Ulbricht, A.; Rinaldi, A.; Civenni, G.; Catapano, C.; Peter, M.; Carr, S.; Garraway, L.; Theurillat, J.P. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S2 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P1405: ARGININE-DEPENDENT REGULATION OF THE EUKARYOTIC TRANSLATION INITIATION FACTOR (EIF)5A CONTROLS HUMAN HEMATOPOIETIC PROGENITOR FATE TO THE ERYTHROID LINEAGE. (23rd June 2022) Authors: Gonzalez-Menendez, P.; Phadke, I.; Olive, M.; Platon, J.; McGraw, K.; Papoin, J.; Yan, H.; Udeshi, N.; Mirmira, R. G.; Narla, A.; Carr, S.; Sitbon, M.; Da Costa, L.; Mohandas, N.; Blanc, L.; Kinet, S.; Taylor, N. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1289 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗